Ho CC - Search Results

1

Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients.

Wu TH, Hsiue EH, Lee JH, Lin CC, Liao WY, Ho CC, Shih JY, Yu CJ, Yang JC. Wu TH, et al. Among authors: ho cc. Clin Lung Cancer. 2018 May;19(3):e361-e372. doi: 10.1016/j.cllc.2018.01.005. Epub 2018 Feb 1. Clin Lung Cancer. 2018. PMID: 29477365

2

Successful treatment of intractable hemothorax with recombinant factor VIIa in a nonhemophilic patient.

Wei YF, Ho CC, Lin MT, Yuan A, Yu CJ. Wei YF, et al. Among authors: ho cc. J Formos Med Assoc. 2006 Sep;105(9):765-9. doi: 10.1016/S0929-6646(09)60206-0. J Formos Med Assoc. 2006. PMID: 16959626 Free article.

3

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy.

Ho CC, Kuo SH, Huang PH, Huang HY, Yang CH, Yang PC. Ho CC, et al. Lung Cancer. 2008 Jan;59(1):105-10. doi: 10.1016/j.lungcan.2007.07.024. Epub 2007 Sep 11. Lung Cancer. 2008. PMID: 17850918

4

TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.

Ho CC, Liao WY, Wang CY, Lu YH, Huang HY, Chen HY, Chan WK, Chen HW, Yang PC. Ho CC, et al. Am J Respir Crit Care Med. 2008 Apr 1;177(7):763-70. doi: 10.1164/rccm.200704-641OC. Epub 2007 Dec 20. Am J Respir Crit Care Med. 2008. PMID: 18096709

5

Adrenal insufficiency in prolonged critical illness.

Wu JY, Hsu SC, Ku SC, Ho CC, Yu CJ, Yang PC. Wu JY, et al. Among authors: ho cc. Crit Care. 2008;12(3):R65. doi: 10.1186/cc6895. Epub 2008 May 8. Crit Care. 2008. PMID: 18466605 Free PMC article.

6

Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.

Ho CC, Chen YC, Hu FC, Yu CJ, Yang PC, Luh KT. Ho CC, et al. Clin Infect Dis. 2009 Jun 1;48(11):1526-33. doi: 10.1086/598929. Clin Infect Dis. 2009. PMID: 19400686

7

Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer.

Wu JY, Shih JY, Yang CH, Chen KY, Ho CC, Yu CJ, Yang PC. Wu JY, et al. Among authors: ho cc. Int J Cancer. 2010 Jan 1;126(1):247-55. doi: 10.1002/ijc.24657. Int J Cancer. 2010. PMID: 19536777

8

Factors influencing visibility and diagnostic yield of transbronchial biopsy using endobronchial ultrasound in peripheral pulmonary lesions.

Huang CT, Ho CC, Tsai YJ, Yu CJ, Yang PC. Huang CT, et al. Among authors: ho cc. Respirology. 2009 Aug;14(6):859-64. doi: 10.1111/j.1440-1843.2009.01585.x. Respirology. 2009. PMID: 19703067

9

Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.

Kuo YW, Wu SG, Ho CC, Shih JY. Kuo YW, et al. Among authors: ho cc. J Thorac Oncol. 2010 Dec;5(12):2039-40. doi: 10.1097/JTO.0b013e3181f43274. J Thorac Oncol. 2010. PMID: 21102267 Free article. No abstract available.

10

Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.

Lin MT, Wei YF, Ku SC, Lin CA, Ho CC, Yu CJ. Lin MT, et al. Among authors: ho cc. J Formos Med Assoc. 2010 Nov;109(11):800-9. doi: 10.1016/S0929-6646(10)60125-8. J Formos Med Assoc. 2010. PMID: 21126652 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

733 results

Search Page

Filters